Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation. (Q33363871)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Raj K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Narayanan S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Augustson B

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ho A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mehta P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Duncan N

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Tauro S

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mahendra P

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mufti G

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

299-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704705

5 January 2020

exact match

0 references

cites work

Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

inferred from DOI database lookup

7 January 2021

based on heuristic

Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704705

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1704705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568036%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 January 2020

1021327409

0 references

1 reference